Geode Capital Management
ELV icon

Geode Capital Management’s Elevance Health ELV Stock Holding History

Geode Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99B Sell
5,166,124
-26,583
-0.5% -$9.86M 0.11% 148
2026
Q1 		$1.51B Buy
5,192,707
+68,108
+1% +$22.4M 0.09% 188
2025
Q4 		$1.8B Sell
5,124,599
-19,305
-0.4% -$6.52M 0.11% 144
2025
Q3 		$1.66B Buy
5,143,904
+50,022
+1% +$15.6M 0.11% 155
2025
Q2 		$1.98B Sell
5,093,882
-72,833
-1% -$29.3M 0.14% 120
2025
Q1 		$2.25B Buy
5,166,715
+202,724
+4% +$81.4M 0.18% 100
2024
Q4 		$1.83B Buy
4,963,991
+115,971
+2% +$48.5M 0.14% 113
2024
Q3 		$2.51B Buy
4,848,020
+85,770
+2% +$45.8M 0.2% 81
2024
Q2 		$2.57B Buy
4,762,250
+67,365
+1% +$35.6M 0.23% 74
2024
Q1 		$2.43B Buy
4,694,885
+177,156
+4% +$88.1M 0.22% 75
2023
Q4 		$2.12B Buy
4,517,729
+97,290
+2% +$45M 0.22% 80
2023
Q3 		$1.92B Buy
4,420,439
+78,981
+2% +$35.8M 0.23% 78
2023
Q2 		$1.92B Buy
4,341,458
+63,121
+1% +$29.1M 0.23% 80
2023
Q1 		$1.96B Buy
4,278,337
+59,126
+1% +$28.1M 0.25% 76
2022
Q4 		$2.16B Buy
4,219,211
+12,281
+0.3% +$6.24M 0.3% 63
2022
Q3 		$1.91B Buy
4,206,930
+75,103
+2% +$35.9M 0.29% 61
2022
Q2 		$1.99B Buy
4,131,827
+135,789
+3% +$67.2M 0.29% 62
2022
Q1 		$1.96B Sell
3,996,038
-178,540
-4% -$81.6M 0.24% 71
2021
Q4 		$1.93B Buy
4,174,578
+51,641
+1% +$21.7M 0.23% 78
2021
Q3 		$1.53B Buy
4,122,937
+161,927
+4% +$61.5M 0.21% 87
2021
Q2 		$1.51B Buy
3,961,010
+171,787
+5% +$65.6M 0.21% 89
2021
Q1 		$1.36B Buy
3,789,223
+60,325
+2% +$19.4M 0.21% 86
2020
Q4 		$1.19B Sell
3,728,898
-4,486
-0.1% -$1.38M 0.2% 93
2020
Q3 		$1B Sell
3,733,384
-43,784
-1% -$11.8M 0.2% 92
2020
Q2 		$992M Buy
3,777,168
+58,127
+2% +$15.5M 0.21% 87
2020
Q1 		$843M Sell
3,719,041
-3,688
-0.1% -$1.01M 0.22% 93
2019
Q4 		$1.12B Buy
3,722,729
+181,091
+5% +$49.8M 0.23% 78
2019
Q3 		$849M Sell
3,541,638
-62,213
-2% -$17M 0.2% 95
2019
Q2 		$1.02B Sell
3,603,851
-24,523
-0.7% -$6.7M 0.25% 76
2019
Q1 		$1.04B Buy
3,628,374
+240,749
+7% +$69.6M 0.27% 71
2018
Q4 		$888M Buy
3,387,625
+273,738
+9% +$75.3M 0.27% 71
2018
Q3 		$852M Buy
3,113,887
+88,557
+3% +$23M 0.24% 78
2018
Q2 		$719M Buy
3,025,330
+94,633
+3% +$21.9M 0.22% 82
2018
Q1 		$642M Buy
2,930,697
+66,673
+2% +$15.7M 0.21% 93
2017
Q4 		$643M Buy
2,864,024
+51,003
+2% +$10.9M 0.22% 88
2017
Q3 		$533M Buy
2,813,021
+83,238
+3% +$15.8M 0.2% 98
2017
Q2 		$513M Buy
2,729,783
+35,362
+1% +$6.35M 0.2% 95
2017
Q1 		$445M Buy
2,694,421
+206,900
+8% +$32.9M 0.18% 111
2016
Q4 		$357M Buy
2,487,521
+114,058
+5% +$15.3M 0.17% 119
2016
Q3 		$297M Buy
2,373,463
+104,535
+5% +$13.5M 0.15% 134
2016
Q2 		$298M Buy
2,268,928
+27,382
+1% +$3.75M 0.16% 120
2016
Q1 		$311K Buy
2,241,546
+43,732
+2% +$5.84M 0.17% 118
2015
Q4 		$306M Buy
2,197,814
+29,570
+1% +$4.07M 0.17% 114
2015
Q3 		$303M Buy
2,168,244
+10,263
+0.5% +$1.54M 0.18% 109
2015
Q2 		$354M Sell
2,157,981
-33,375
-2% -$5.33M 0.2% 102
2015
Q1 		$338M Buy
2,191,356
+63,440
+3% +$9.03M 0.19% 103
2014
Q4 		$267M Buy
2,127,916
+44,132
+2% +$5.45M 0.16% 127
2014
Q3 		$249M Sell
2,083,784
-48,463
-2% -$5.56M 0.16% 127
2014
Q2 		$229M Sell
2,132,247
-40,375
-2% -$4.16M 0.15% 143
2014
Q1 		$216M Sell
2,172,622
-49,227
-2% -$4.45M 0.15% 145
2013
Q4 		$205M Buy
2,221,849
+121,931
+6% +$10.8M 0.14% 144
2013
Q3 		$176M Buy
2,099,918
+45,490
+2% +$3.9M 0.14% 143
2013
Q2 		$168M Buy
+2,054,428
New +$154M 0.15% 133

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's ELV Position: Q2 2026 in Review

Geode Capital Management reduced its Elevance Health (ELV) stake by 0.51% in Q2 2026, selling an estimated $9.86M and leaving 5,166,124 shares worth $1.99B. The position accounts for 0.11% of the portfolio, ranked #148.

Geode Capital Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.57B in Q2 2024. 1,311 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Geode Capital Management held 5,166,124 shares of Elevance Health worth $1.99B as of Q2 2026.
  • Geode Capital Management sold 26,583 Elevance Health shares in Q2 2026, an estimated $9.86M.
  • Elevance Health made up 0.11% of Geode Capital Management's portfolio in Q2 2026, its #148 holding.
  • Geode Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Geode Capital Management's Elevance Health position peaked at $2.57B in Q2 2024.
  • 1,311 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.